4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-063297
SVP & Chief Scientific Officer acquired 23,950 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2018-12-14 | Grant or award | +23,950 | 102,684 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2018-12-14 | Grant or award · Stock Option | +48,400 | 48,400 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…